Basics C4 Therapeutics, Inc. IPO Date: October 2, 2020 Sector: Healthcare Industry: Biotech Market Cap: $92.31M Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.86% Avg Daily Range (30 D): $0.07 | 4.88% Avg Daily Range (90 D): $0.08 | 4.14% Institutional Daily Volume Avg Daily Volume: 1.34M Avg Daily Volume (30 D): .98M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 141 Avg Trade Size (Sh.) (30 D): 181 Avg Trade Size (Sh.) (90 D): 154 Institutional Trades Total Inst.Trades: 1,033 Avg Inst. Trade: $1.93M Avg Inst. Trade (30 D): $.76M Avg Inst. Trade (90 D): $2.59M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.18M Avg Closing Trade (30 D): $.76M Avg Closing Trade (90 D): $.94M Avg Closing Volume: 177.54K         News May 7, 2025 @ 11:00 AM C4 Therapeutics Reports First Quarter 2025 Financi... Source: C4 Therapeutics Jan 29, 2025 @ 6:00 PM BRAF Inhibitors Market to Register Incremental Gro... Source: Delveinsight Jan 9, 2025 @ 3:53 PM NUT Midline Carcinoma Treatment Market Research Re... Source: Researchandmarkets.Com Dec 8, 2024 @ 5:30 PM C4 Therapeutics Presents Cemsidomide Phase 1 Data ... Source: N/A Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.37 $-.35 $-.26 Diluted EPS $-.37 $-.35 $-.26 Revenue $ 7.24M $ 15.36M $ 12.01M Gross Profit $ $ $ Net Income / Loss $ -26.32M $ -24.67M $ -17.72M Operating Income / Loss $ -29.16M $ -28.24M $ -21.44M Cost of Revenue $ $ $ Net Cash Flow $ -4.21M $ -13.47M $ -16.55M PE Ratio